Don’t Forget to Address Autoimmune Comorbidities of Atopic Dermatitis
Dermatology Times
JUNE 9, 2024
Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.
Sun.Jun 09, 2024
92 
Zucchini and Quinoa Breakfast Bowl
Alison Bladh
JUNE 9, 2024
Zucchini and Quinoa Breakfast Bowl Start your day with this Zucchini and Quinoa Breakfast Bowl, a delightful combination of wholesome quinoa and fresh zucchini. This nutrient-packed dish is perfect for a light yet satisfying breakfast. The added freshness from the herbs and the slight crunch of the veggies make it a perfect start to your morning. Ingredients: For the Breakfast Bowl: • 1 cup cooked quinoa (180 g / 6 oz) • 1 medium zucchini (about 200 g / 7 oz), spiralised or grated • 1/2 cup cher
Considerations for Topical Therapeutics and Clinical Excellence in Vitiligo
Dermatology Times
JUNE 9, 2024
Nanette Silverberg, MD, shares data on the efficacy of on- and off-label therapeutics for vitiligo, as well as the importance of communication with patients to promote clinical excellence.
Day 1 Recap: 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference
Dermatology Times
JUNE 9, 2024
Catch up on coverage from the first day of the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference in Chicago, Illinois.
Upadacitinib Demonstrates Continued Improvements in Patients With Moderate to Severe AD Through 140 Weeks
Dermatology Times
JUNE 9, 2024
Improvements in patient-reported outcomes were higher among patients treated with upadacitinib 30mg versus 15mg.
Spotlighting Vitiligo: New Innovations to be Presented at RAVE 2024
Dermatology Times
JUNE 9, 2024
Nanette Silverberg, MD, shares her excitement about the inclusion of vitiligo at this year’s RAVE meeting.
Sign up to get articles personalized to your interests!
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
More Trending
Ritlecitinib Shows Promising Results in Long-Term Trial
Dermatology Times
JUNE 9, 2024
Researchers found patients with less than 95% hair loss at baseline reached median SALT score 2.4 or less, reflecting almost complete hair regrowth.
A RAVE Upgrade: Previewing Revolutionizing Alopecia Areata, Vitiligo, and Eczema
Dermatology Times
JUNE 9, 2024
Jonathan Silverberg, MD, PhD, MPH, shares insights into the change of this year’s meeting and the benefit of additional disease states.
Serum CXCL10 Levels Decreased With Use of Ruxolitinib Cream In Patients With Vitiligo
Dermatology Times
JUNE 9, 2024
Data from the TRuE-V mechanism of action study was presented in a poster at the 2024 RAVE Conference.
Oncodermatology: An Emerging Field
Dermatology Times
JUNE 9, 2024
At the SPDA conference, Meghan Heberton, MD, told attendees about the importance of oncodermatology in patient care.
What to Expect at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference
Dermatology Times
JUNE 9, 2024
The inaugural RAVE conference begins today in Chicago, Illinois.
SDPA Membership Ratifies Name Change and Embraces “Associate”
Dermatology Times
JUNE 9, 2024
SDPA President Laura Bush DMSc, PA-C, DFAAPA, shares exciting news about the name change as the Summer Conference begins to wind down.
Let's personalize your content